Product Information
DEXMETHYLPHENIDATE 2.5 MG TAB is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.1900 per EA under NDC 57664037688. Its NADAC has been published 565 times since Dec 9, 2015.
FDA first approved this application on Sep 24, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
57664037688
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXMETHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA201231FDA Approved
9/24/2015
TE Code
AB
On Market Since
9/26/2013
Pharmacological Classes
Price Statistics
The NADAC for DEXMETHYLPHENIDATE 2.5 MG TAB has been published 565 times since Dec 9, 2015, and over the history we have for it it has declined 58.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1900 per EA |
|---|---|
| All-time high | $0.4980 (Apr 13, 2016) |
| All-time low | $0.0914 (Dec 21, 2022) |
| 52-week high | $0.2175 |
| 52-week low | $0.1859 |
| Median price | $0.1929 |
| Average price | $0.2459 |
| Largest weekly change | +67.3% (Oct 18, 2023) |
| Weeks tracked | 565 |
| Tracking since | Dec 9, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dexmethylphenidate hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dexmethylphenidate hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXMETHYLPHENIDATE 2.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DEXMETHYLPHENIDATE 2.5 MG TAB, manufactured by Sun Pharmaceutical Industries Inc., is $0.1900 per EA (NDC 57664037688), effective Sep 30, 2026.
How has the price of DEXMETHYLPHENIDATE 2.5 MG TAB changed over time?
Over the history we have for it, the NADAC for DEXMETHYLPHENIDATE 2.5 MG TAB has declined 58.7%. It has been tracked across 565 weekly CMS publications since Dec 9, 2015.
What are the highest and lowest recorded NADAC prices for DEXMETHYLPHENIDATE 2.5 MG TAB?
Since Dec 9, 2015, the NADAC for DEXMETHYLPHENIDATE 2.5 MG TAB has ranged from a low of $0.0914 (Dec 21, 2022) to a high of $0.4980 (Apr 13, 2016), with a median of $0.1929 per EA.
Are there cheaper alternatives to DEXMETHYLPHENIDATE 2.5 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of DEXMETHYLPHENIDATE 2.5 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DEXMETHYLPHENIDATE 2.5 MG TAB?
DEXMETHYLPHENIDATE 2.5 MG TAB (NDC 57664037688) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.